Contact Us
  • Next-Gen Treatment

Tirzepatide Injections

The most effective weight loss medication in clinical history — up to 22% body weight reduction.
Max weight loss
0 %

SURMOUNT

Clinical trial

Dual

Mechanism of action

  • Strongest Results Available

What is Tirzepatide?

Tirzepatide is the next generation of weight loss injection — a dual GIP/GLP-1 receptor agonist. Unlike Semaglutide, which targets only GLP-1 receptors, Tirzepatide simultaneously activates both GIP and GLP-1 receptors, producing dramatically enhanced weight loss.
In the landmark SURMOUNT-1 clinical trial, patients on the highest dose of Tirzepatide lost an average of 22.5% of their body weight — more than any weight loss medication ever studied.
/ first month
$ 0
$399/mo ongoing · Cancel anytime
  • 30-day Tirzepatide supply (2.5mg)
  • Licensed provider consultation
  • Dual GIP/GLP-1 mechanism
  • Free shipping · Monthly check-in
Contact Us
View Pricing
Comparison

Semaglutide vs. Tirzepatide

Feature Semaglutide Tirzepatide ★
Mechanism
GLP-1 only
GLP-1 + GIP (dual)
Avg. weight loss
~15%
Up to 22%
Injection frequency
Weekly
Weekly
Starting dose
0.25mg/week
0.25mg/week
Starting price
$249/mo
$349/mo
Best for
First-time GLP-1 users
Maximum weight loss results
Clinical trial
STEP 1
SURMOUNT-1